Prostate cancer screening behavior in men from seven ethnic groups: The fear factor

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 2, 2006, Pages 228-237

  Consedine, Nathan S ^a   Morgenstern, Amy H ^b   Kudadjie Gyamfi, Elizabeth ^a   Magai, Carol ^a   Neugut, Alfred I ^c  

^a LONG ISLAND UNIVERSITY   (United States)

^b Intercultural Institute on Human Development and Aging   (United States)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER SCREENING; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DOMINICAN REPUBLIC; ETHNOLOGY; EUROPEAN AMERICAN; FEAR; HAITI; HEALTH BEHAVIOR; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; DIGITAL RECTAL EXAMINATION; EMOTIONS; ETHNIC GROUPS; FEAR; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEW YORK; PERSONALITY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 33644766715     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0019     Document Type: Article

References (97)

1. Crawford ED. Epidemiology of prostate cancer. Urology 2003;62:3-12.
2. ACS. Cancer facts and figures, 2004. Atlanta (GA): American Cancer Society; 2004.
3. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
4. O'Brien K, Cokkinides V, Jemal A, et al. Cancer statistics for Hispanics, 2003. CA Cancer J Clin 2003;53:208-26.
5. Bunker CH, Patrick AL, Konety BR, et al. High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey. Cancer Epidemiol Biomarkers Prev 2002;11:726-9.
6. Bunker CH, Patrick AL, Miljkovic-Gacic I, et al. Prostate cancer screening parameters in a high-risk African-Caribbean population. Urology 2004;63:737-41.
7. Glover FE, Coffey DS, Douglas LL, et al. The epidemiology of prostate cancer in Jamaica. J Urol 1998;159:1984-6.
8. Targonski PV, Guinan P, Phillips CW. Prostate cancer: the stage disadvantage in the Black male. J Natl Med Assoc 1991;83:1094-6.
9. Delfino RJ, Errini RL, Taylor TH, Howe S, Anton-Culver H. Demographic differences in prostate cancer incidence and stage: an examination of population diversity in California. Am J Prev Med 1998;14:96-102.
10. Polednak AP, Flannery JT. Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer 1992;70:2152-8.
11. Danley KL, Richardson JL, Bernstein L, Langholz B, Ross RK. Prostate cancer: trends in mortality and stage-specific incidence rates by racial/ethnic group in Los Angeles County, California. Cancer Causes Control 1995;6:492-8.
12. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999;91:1409-15.
13. Myers RE. Adherence by African American men to prostate cancer education and early detection. Cancer 1999;86:88-104.
14. Ashford A, Gemson DH, Sheinfeld-Gorin SN, et al. Cancer screening and prevention practices of inner city physicians. Am J Prev Med 2000;19:59-62.
15. Moul JW. Screening for prostate cancer in African Americans. Curr Urol Rep 2000;1:57-64.
16. Thompson I, Tangen C, Tolcher A, et al. Association of African-American ethnic background with survival in men with metastatic prostate cancer. J Natl Cancer Inst 2001;93:219-25.
17. Farkas A, Marcella S, Rhoades GG. Ethnic and racial differences in prostate cancer incidence and mortality. Ethn Dis 2000;10:69-75.
18. Farkas A, Schneider D, Perrotti M, Cummings KB, Ward WS. National trends in the epidemiology of prostate cancer, 1973 to 1994: evidence for the effectiveness of prostate-specific antigen screening. Urology 1998;52:448-9.
19. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2004. CA Cancer J Clin 2004;54:41-52.
20. ACS. Cancer facts and figures for African Americans 2003-2004. Atlanta (GA): ACS Inc; 2003.
21. Conlisk EA, Lengerich EJ, Demark-Wahnefried W, Schildkraut JM, Aldrich TE. Prostate cancer: demographic and behavioral correlates of stage at diagnosis among Blacks and Whites in North Carolina. Urology 1999;53:1194-9.
22. Cotter MP, Gern RW, Ho GYF, Chang RY, Burk RD. Role of family history and ethnicity on the mode and age of prostate cancer presentation. Prostate 2002;50:216-21.
23. Tingen MS, Weinrich SP, Heydt DD, Boyd MD, Weinrich MC. Perceived benefits: a predictor of participation in prostate cancer screening. Cancer Nurs 1998;21:349-37.
24. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin 2004;54:78-93.
25. Wilkinson S, List M, Sinner M, Dai L, Chodak G. Educating African-American men about prostate cancer: impact on awareness and knowledge. Urology 2003;61:308-13.
26. Steele CB, Miller DS, Maylahn C, Uhler RJ, Baker CT. Knowledge, attitudes, and screening practices among older men regarding prostate cancer. Am J Public Health 2000;90:1595-600.
27. Merrill RM. Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah. Prev Med 2001;33:346-652.
28. Demark-Wahnefried W, Catoe KE, Paskett E, Robertson CN, Rimer BK. Characteristics of men reporting for prostate cancer screening. Urology 1993;42:269-74.
29. Eisen SA, Waterman B, Skinner CS, et al. Sociodemographic and health status characteristics associated with prostate cancer screening in a national cohort of middle-aged male veterans. Urology 1999;53:516-22.
30. Myers RE, Hyslop T, Jennings-Dozier K, et al. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomarkers Prev 2000;9:1323-8.
31. Weinrich SP, Reynolds WA, Tingen MS, Starr CR. Barriers to prostate cancer screening. Cancer Nurs 2000;23:117-21.
32. Weinrich SP, Weinrich MC, Priest J, Fodi C. Self-reported reasons men decide not to participate in free prostate cancer screening. Oncol Nurs Forum 2003;30:E12-6.
33. Boyd M, Weinrich S, Weinrich M, Norton A. Obstacles to prostate cancer screening in African American men. J Black Nurses Assoc 2001;12:1-5.
34. Clarke-Tasker VA, Wade R. What we thought we knew: African American males' perceptions of prostate cancer and screening methods. Assoc Black Nurs Faculty Higher Educ J 2002;13:56-60.
35. Bach PB, Cramer LD, Warren JL, Begg CB. Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198-205.
36. O'Malley AS, Kerner J, Johnson AE, Mandelblatt JS. Acculturation and breast cancer screening among Hispanic women in New York City. Am J Public Health 1999;89:219-27.
37. Consedine NS, Magai C, Cohen CI, Gillespie M. Ethnic variation in the impact of negative affect and emotion inhibition on the health of older adults. J Gerontol B Psychol Sci Soc Sci 2002;57B:396-408.
38. Gopaul-McNicol S. Ethnocultural perspectives on childrearing practices in the Caribbean. Int Soc Work 1999;42:79-86.
39. Consedine NS, Magai C, Conway F. Predicting ethnic variation in adaptation to later life: styles of socioemotional functioning and constrained heterotypy. J Cross Cult Gerontol 2004;19:95-129.
40. Ramirez AG, Suarez L, Laufman L, Barroso C, Chalela P. Hispanic women's breast and cervical knowledge, attitudes, and screening behavior. Am J Public Health 2000;14:292-300.
41. Suarez L, Ramirez AG, Villarreal R, et al. Social networks and cancer screening in four U S. Hispanic groups. Am J Prev Med 2000;19:47-52.
42. Agho AO, Lewis MA. Correlates of actual and perceived knowledge of prostate cancer among African Americans. Cancer Nurs 2001;24:165-71.
43. Myers RE, Wolf TA, McKee L, et al. Factors associated with intention to undergo annual prostate cancer screening among African American men in Philadelphia. Cancer 1996;78:471-9.
44. Kunkel EJS, Meyer B, Daskalakis C, et al. Behaviors used by men to protect themselves against prostate cancer. Cancer Epidemiol Biomarkers Prev 2004;13:78-86.
45. Vadaparampil ST, Jacobson PB, Kash K, et al. Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 2004;13:753-8.
46. Odedina FT, Scrivens J, Emanuel A, et al. A focus group study of factors influencing African-American men's prostate cancer screening behavior. J Natl Med Assoc 2004;96:780-8.
47. Magai C, Consedine NS, Conway F, Neugut AI, Culver C. Diversity matters: unique populations of older women and breast cancer screening. Cancer 2004;100:2300-7.
48. Consedine NS, Magai C, Neugut AI. The contribution of emotional characteristics to breast cancer screening among women from six ethnic groups. Prev Med 2004;38:64-77.
49. Steginga SK, Occhipinti S, McCaffrey J, Dunn J. Men's attitudes toward prostate cancer and seeking prostate-specific antigen testing. J Cancer Educ 2001;16:42-5.
50. Beebe-Dimmer JL, Wood DJJ, Gruber SB, et al. Risk perception and concern among brothers of men with prostate carcinoma. Cancer 2004;100:1537-44.
51. Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut AI. Fear, anxiety, worry, and breast cancer screening behavior: a critical review. Cancer Epidemiol Biomarkers Prev 2004;13:1-10.
52. Vernon SW, Laville EA, Jackson GL. Participation in breast screening programs: a review. Soc Sci Med 1990;30:1107-18.
53. Bloom J, Hayes W, Saunders F, et al. Cancer awareness and secondary prevention practices in Black Americans: implications for intervention. Fam Community Health 1987;10:19-30.
54. Miller LY, Hailey BJ. Cancer anxiety and breast cancer screening in African-American women: a preliminary study. Womens Health Inst 1994;4:170-4.
55. Austin L, Ahmad F, McNally MJ, Steward D. Breast and cervical cancer screening in Hispanic women: a literature review using the Health Belief Model. Womens Health Issues 2002;12:122-8.
56. Friedman LC, Webb JA, Weinberg AD, Lane M, Cooper HP. Breast cancer screening: racial/ethnic differences in behaviors and beliefs. J Cancer Educ 1995;10:213-6.
57. Aro AR, de Koning HJ, Absetz P, Schreck M. Two distinct groups of non-attenders in an organized mammography screening program. Breast Cancer Res Treat 2001;70:145-53.
58. Ciatto S, Cecchini S, Isu A, Maggi A, Camelli S. Determinants of non-attendance to mammographic screening: analysis of a population sample of the screening program in the District of Florence. Tumori 1992;78:22-5.
59. Donate F, Bollani A, Spiazzi R, et al. Factors associated with non-participation of women in a breast cancer screening programme in a town in northern Italy. J Epidemiol Community Health 1991;45:59-64.
60. Edwards NI, Jones DA. Uptake of breast cancer screening in older women. Age Ageing 2000;29:131-5.
61. Caplan LS, Helzlsouer KJ, Shapiro S, Wesley MN, Edwards BK. Reasons for delay in breast cancer diagnosis. Prev Med 1996;25:218-24.
62. McCaul KD, Branstetter AD, O'Donnell SM, Jacobson K, Quinlan KB. A descriptive study of breast cancer worry. J Behav Med 1998;21:565-79.
63. Lagerlund M, Hedin A, Sparen P, Thurfell E, Lambe M. Attitudes, beliefs, and knowledge as predictors of nonattendance in a Swedish population-based mammography screening program. Prev Med 2000;31:417-28.
64. Dale W, Bilir P, Han M, Meltzer D. The role of anxiety in prostate carcinoma. Cancer 2005;104:467-78.
65. Consedine NS, Magai C, Bonanno GA. Moderators of the emotion inhibition-health relationship: a review and research agenda. Rev Gen Psychol 2002;6:204-28.
66. Powell DR. Social and psychological aspects of breast cancer in African-American women. Ann N Y Acad Sci 1994;736:131-9.
67. Goldstein DA, Antoni MH. The distribution of repressive coping styles among non-metastatic and metastatic breast cancer patients and compared to non-cancer patients. Psychol Health 1989;3:245-58.
68. Kreitler S, Chaitchik S, Kreitler H. The psychological profile of women attending breast-screening tests. Soc Sci Med 1990;31:1177-85.
69. Andersen MR, Smith R, Meischke H, Bowen D, Urban N. Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev 2003;12:314-20.
70. Althausen L, Russian families. In: McGoldrick M, Giordano J, Pearce JK, editors. Ethnicity and family therapy. New York: Guilford; 1996. p. 680-7.
71. Margonoff PP, Folwarski J. Russian/Ukrainian families: an overview. In: Pearce JK, editor. Ethnicity and family therapy. New York: Guilford; 1996. p. 685-72.
72. Hall HI, Van Den Eeden SK, Tolsma DD, et al. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med 2004;39:27-35.
73. Jordan TR, Price JH, King KA, Masyk T, Bedell AW. The validity of male patients' self reports regarding prostate cancer screening. Prev Med 1999;28:297-303.
74. Tabachinick BG, Fidell IS. Using multivariate statistics. Boston (MA): Allyn and Bacon; 2001.
75. Izard CE. Patterns of emotions: a new analysis of anxiety and depression. New York: Academic Press; 1972.
76. Youngstrom EA, Green KW. Reliability generalization of self-report of emotions when using the Differential Emotions Scale. Educ Psychol Measurement 2003;63:279-95.
77. Miller SM. Monitoring and blunting: validation of a questionnaire to assess styles of information seeking under threat. J Personal Soc Psychol 1987;52:345-53.
78. Steptoe A, O'Sullivan J. Monitoring and blunting coping styles in women prior to surgery. Br J Clin Psychol 1986;25:143-4.
79. Williams-Piehota P, Pizarro J, Schneider TR, Mowad L, Salovey P. Matching health messages to monitor-blunter coping styles to motivate screening mammography. Health Psychol 2005;2:58-67.
80. Nordin K, Liden A, Hansson M, Rosenquist R, Berglund G. Coping style, psychological distress, risk perception, and satisfaction in subjects attending genetic counselling for hereditary cancer. J Med Genet 2002;39:689-94.
81. Miller SM. Monitoring versus blunting styles of coping with cancer influence the information patients want and need about their disease. Cancer 1995;76:167-77.
82. Miller SM. Monitoring and blunting of threatening information: cognitive interference and facilitation in the coping process. In: Sarason IG, Pierce GR, Sarason BR, editors, Cognitive interference. Theories, methods, and findings. Mahwah (NJ): Lawrence Erlbaum Associates; 1996. p. 175-90.
83. Miller SM, Buzaglo JS, Simms SL, et al. Monitoring styles in women at risk for cervical cancer: implications for the framing of health-relevant messages. Ann Behav Med 1999;21:27-34.
84. Miller SM, Leinbach A, Brody DS. Coping style in hypertensive patients: nature and consequences. J Consult Clin Psychol 1989;57:333-7.
85. Steptoe A. An abbreviated version of the Miller Monitor Blunter Scale. Br J Clin Psychol 1989;28:183-4.
86. Consedine NS, Magai C. The uncharted waters of emotion: ethnicity, trait emotion and emotion expression in older adults. J Cross Cult Gerontol 2002;17:71-100.
87. Breen N, Waegner KK, Brown MI, Davis William W, Ballard-Barbash R. Progress in cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13.
88. Fox SA, Roetzheim RG. Screening mammography and older Hispanic women: current status and issues. Cancer 1994;74:2028-33.
89. Fulton JP, Rakowski W, Jones AC. Determinants of breast cancer screening among inner-city Hispanic women in comparison with other inner-city women. Public Health Rep 1995;110:476-82.
90. Hoffman-Goetz L, Breen NL, Meissner H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis 1998;8:43-51.
91. Mandelblatt JS, Gold K, O'Malley AS, et al. Breast and cervix cancer screening among multiethnic women: role of age, health and source of care. Prev Med 1999;28:418-25.
92. Borrayo EA, Guarnaccia CA. Differences in Mexican-born and U S.-born women of Mexican descent regarding factors related to breast cancer screening behaviors. Health Care Women Int 2000;21:599-613.
93. Mora PA, Robitaille C, Leventhal H, Swigar M, Leventhal EA. Trait negative affect relates to prior-week symptoms, but not to reports of illness episodes, illness symptoms, and care seeking among older persons. Psychosom Med 2002;64:436-49.
94. Roumier X, Azzouzi R, Valeri A, et al. Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer. Eur Urol 2004;45:280-6.
95. Miller SM, Fang CY, Manne SL, Engstrom PF, Daly MB. Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. Gynecol Oncol 1999;75:406-12.
96. Fang CY, Miller SM, Daly MB, Hurley K. The influence of attentional style and risk perceptions on intentions to undergo prophylactic oophorectomy among first-degree relatives. Psychol Health 2000;17:364-75.
97. Miller SM, Rodoletz M, Schroeder CM, Mangan CE, Sedlacek TV. Applications of the monitoring process model to coping with severe long-term medical threats. Health Psychol 1996;15:216-25.